false 869587 <![CDATA[2007 Physicians' Desk Reference (Physicians' Desk Reference (Pdr))]]> http://photo.goodreads.com/books/1179053764m/869587.jpg http://photo.goodreads.com/books/1179053764s/869587.jpg Physicians have turned to PDR for the latest word on prescription drugs for over 60 years! Today, PDR is considered the standard prescription drug reference and can be found in virtually every physician's office, hospital, and pharmacy in the United States. In fact, nine out of 10 doctors consider PDR their most important drug information reference source.

The 61st edition contains more than 3,000 pages—our most comprehensive edition ever! Our new format allows dramatically improved readability and easier access to the information you need now. Among the new drugs featured in this edition are:

Amitiza (lubiprostone), a new locally acting chloride-channel activator for the oral treatment of chronic idiopathic constipation in adults

Daytrana (methylphenidate transdermal system), a new once-daily transdermal patch formulation of methylphenidate for the treatment of attention deficit hyperactivity disorder

Nexavar (sorafenib), a new multi-kinase inhibitor for the treatment of patients with advanced renal cell carcinoma

Proquad a new live vaccine for simultaneous vaccination against measles, mumps, rubella (German measles) and varicella (chickenpox) in children 12 months to 12 years of age (Proquad is also approved for use in children 12 months to 12 years of age if a second dose of measles, mumps, and rubella vaccine is to be administered)

Ranexa (ranolazine extended-release tablets), a new anti-anginal for the treatment of chronic angina

Rotateq (rotavirus vaccine, live, oral, pentavalent), a new vaccine for the prevention of rotavirus gastroenteritis in infants and children

Sutent (sunitinib malate), a new multi-kinase inhibitor for patients with advanced renal cell carcinoma, and gastrointestinal stromal tumor after disease progression on, or intolerance to, imatinib mesylate

Vivaglobin (immune globulin subcutaneous [human]), a new immune globulin for the treatment of patients with primary immunodeficiency.

You'll find the most complete data on more than 4,000 drugs by brand and generic name (both in the same convenient index), manufacturer, and product category.

Your 2007 PDR provides usage information and warnings, drug interactions, plus more than 2,000 full-size, full-color photos cross-referenced to the drug. You will also find: > Phonetic spelling for each listing > A key to controlled substances > Dosages > Clinical pharmacology > FDA use-in-pregnancy ratings > Adverse reactions > Contraindications > Pediatric use > And all other FDA-required information

]]> 869587 1 854970 30 11 2006 2007 Physicians' Desk Reference (Physicians' Desk Reference (Pdr)) total:10|5:4|4:5|3:1|2:0|1:0| 10 43 13 1 3413 4.36 11 1 34010982 1559580 869587 1563635682 9781563635687 1 <![CDATA[2007 Physicians' Desk Reference]]> http://photo.goodreads.com/books/1179053764m/869587.jpg http://photo.goodreads.com/books/1179053764s/869587.jpg http://www.goodreads.com/book/show/869587.2007_Physicians_Desk_Reference 4.30 10 Physicians have turned to PDR for the latest word on prescription drugs for over 60 years! Today, PDR is considered the standard prescription drug reference and can be found in virtually every physician's office, hospital, and pharmacy in the United States. In fact, nine out of 10 doctors consider PDR their most important drug information reference source.

The 61st edition contains more than 3,000 pages—our most comprehensive edition ever! Our new format allows dramatically improved readability and easier access to the information you need now. Among the new drugs featured in this edition are:

Amitiza (lubiprostone), a new locally acting chloride-channel activator for the oral treatment of chronic idiopathic constipation in adults

Daytrana (methylphenidate transdermal system), a new once-daily transdermal patch formulation of methylphenidate for the treatment of attention deficit hyperactivity disorder

Nexavar (sorafenib), a new multi-kinase inhibitor for the treatment of patients with advanced renal cell carcinoma

Proquad a new live vaccine for simultaneous vaccination against measles, mumps, rubella (German measles) and varicella (chickenpox) in children 12 months to 12 years of age (Proquad is also approved for use in children 12 months to 12 years of age if a second dose of measles, mumps, and rubella vaccine is to be administered)

Ranexa (ranolazine extended-release tablets), a new anti-anginal for the treatment of chronic angina

Rotateq (rotavirus vaccine, live, oral, pentavalent), a new vaccine for the prevention of rotavirus gastroenteritis in infants and children

Sutent (sunitinib malate), a new multi-kinase inhibitor for patients with advanced renal cell carcinoma, and gastrointestinal stromal tumor after disease progression on, or intolerance to, imatinib mesylate

Vivaglobin (immune globulin subcutaneous [human]), a new immune globulin for the treatment of patients with primary immunodeficiency.

You'll find the most complete data on more than 4,000 drugs by brand and generic name (both in the same convenient index), manufacturer, and product category.

Your 2007 PDR provides usage information and warnings, drug interactions, plus more than 2,000 full-size, full-color photos cross-referenced to the drug. You will also find: > Phonetic spelling for each listing > A key to controlled substances > Dosages > Clinical pharmacology > FDA use-in-pregnancy ratings > Adverse reactions > Contraindications > Pediatric use > And all other FDA-required information

]]> 2006 5 0 false Sat Sep 27 20:58:16 -0700 2008 Sun Sep 28 18:35:30 -0700 2008 80991846 3043050 869587 1563635682 9781563635687 1 <![CDATA[2007 Physicians' Desk Reference]]> http://photo.goodreads.com/books/1179053764m/869587.jpg http://photo.goodreads.com/books/1179053764s/869587.jpg http://www.goodreads.com/book/show/869587.2007_Physicians_Desk_Reference 4.30 10 Physicians have turned to PDR for the latest word on prescription drugs for over 60 years! Today, PDR is considered the standard prescription drug reference and can be found in virtually every physician's office, hospital, and pharmacy in the United States. In fact, nine out of 10 doctors consider PDR their most important drug information reference source.

The 61st edition contains more than 3,000 pages—our most comprehensive edition ever! Our new format allows dramatically improved readability and easier access to the information you need now. Among the new drugs featured in this edition are:

Amitiza (lubiprostone), a new locally acting chloride-channel activator for the oral treatment of chronic idiopathic constipation in adults

Daytrana (methylphenidate transdermal system), a new once-daily transdermal patch formulation of methylphenidate for the treatment of attention deficit hyperactivity disorder

Nexavar (sorafenib), a new multi-kinase inhibitor for the treatment of patients with advanced renal cell carcinoma

Proquad a new live vaccine for simultaneous vaccination against measles, mumps, rubella (German measles) and varicella (chickenpox) in children 12 months to 12 years of age (Proquad is also approved for use in children 12 months to 12 years of age if a second dose of measles, mumps, and rubella vaccine is to be administered)

Ranexa (ranolazine extended-release tablets), a new anti-anginal for the treatment of chronic angina

Rotateq (rotavirus vaccine, live, oral, pentavalent), a new vaccine for the prevention of rotavirus gastroenteritis in infants and children

Sutent (sunitinib malate), a new multi-kinase inhibitor for patients with advanced renal cell carcinoma, and gastrointestinal stromal tumor after disease progression on, or intolerance to, imatinib mesylate

Vivaglobin (immune globulin subcutaneous [human]), a new immune globulin for the treatment of patients with primary immunodeficiency.

You'll find the most complete data on more than 4,000 drugs by brand and generic name (both in the same convenient index), manufacturer, and product category.

Your 2007 PDR provides usage information and warnings, drug interactions, plus more than 2,000 full-size, full-color photos cross-referenced to the drug. You will also find: > Phonetic spelling for each listing > A key to controlled substances > Dosages > Clinical pharmacology > FDA use-in-pregnancy ratings > Adverse reactions > Contraindications > Pediatric use > And all other FDA-required information

]]> 2006 5 0 false Mon Dec 14 12:34:22 -0800 2009 Mon Dec 14 12:34:22 -0800 2009 74570636 2169435 869587 1563635682 9781563635687 1 <![CDATA[2007 Physicians' Desk Reference]]> http://photo.goodreads.com/books/1179053764m/869587.jpg http://photo.goodreads.com/books/1179053764s/869587.jpg http://www.goodreads.com/book/show/869587.2007_Physicians_Desk_Reference 4.30 10 Physicians have turned to PDR for the latest word on prescription drugs for over 60 years! Today, PDR is considered the standard prescription drug reference and can be found in virtually every physician's office, hospital, and pharmacy in the United States. In fact, nine out of 10 doctors consider PDR their most important drug information reference source.

The 61st edition contains more than 3,000 pages—our most comprehensive edition ever! Our new format allows dramatically improved readability and easier access to the information you need now. Among the new drugs featured in this edition are:

Amitiza (lubiprostone), a new locally acting chloride-channel activator for the oral treatment of chronic idiopathic constipation in adults

Daytrana (methylphenidate transdermal system), a new once-daily transdermal patch formulation of methylphenidate for the treatment of attention deficit hyperactivity disorder

Nexavar (sorafenib), a new multi-kinase inhibitor for the treatment of patients with advanced renal cell carcinoma

Proquad a new live vaccine for simultaneous vaccination against measles, mumps, rubella (German measles) and varicella (chickenpox) in children 12 months to 12 years of age (Proquad is also approved for use in children 12 months to 12 years of age if a second dose of measles, mumps, and rubella vaccine is to be administered)

Ranexa (ranolazine extended-release tablets), a new anti-anginal for the treatment of chronic angina

Rotateq (rotavirus vaccine, live, oral, pentavalent), a new vaccine for the prevention of rotavirus gastroenteritis in infants and children

Sutent (sunitinib malate), a new multi-kinase inhibitor for patients with advanced renal cell carcinoma, and gastrointestinal stromal tumor after disease progression on, or intolerance to, imatinib mesylate

Vivaglobin (immune globulin subcutaneous [human]), a new immune globulin for the treatment of patients with primary immunodeficiency.

You'll find the most complete data on more than 4,000 drugs by brand and generic name (both in the same convenient index), manufacturer, and product category.

Your 2007 PDR provides usage information and warnings, drug interactions, plus more than 2,000 full-size, full-color photos cross-referenced to the drug. You will also find: > Phonetic spelling for each listing > A key to controlled substances > Dosages > Clinical pharmacology > FDA use-in-pregnancy ratings > Adverse reactions > Contraindications > Pediatric use > And all other FDA-required information

]]> 2006 4 0 false Wed Oct 14 18:54:16 -0700 2009 Wed Oct 14 18:54:16 -0700 2009 52137564 2206930 869587 1563635682 9781563635687 1 <![CDATA[2007 Physicians' Desk Reference]]> http://photo.goodreads.com/books/1179053764m/869587.jpg http://photo.goodreads.com/books/1179053764s/869587.jpg http://www.goodreads.com/book/show/869587.2007_Physicians_Desk_Reference 4.30 10 Physicians have turned to PDR for the latest word on prescription drugs for over 60 years! Today, PDR is considered the standard prescription drug reference and can be found in virtually every physician's office, hospital, and pharmacy in the United States. In fact, nine out of 10 doctors consider PDR their most important drug information reference source.

The 61st edition contains more than 3,000 pages—our most comprehensive edition ever! Our new format allows dramatically improved readability and easier access to the information you need now. Among the new drugs featured in this edition are:

Amitiza (lubiprostone), a new locally acting chloride-channel activator for the oral treatment of chronic idiopathic constipation in adults

Daytrana (methylphenidate transdermal system), a new once-daily transdermal patch formulation of methylphenidate for the treatment of attention deficit hyperactivity disorder

Nexavar (sorafenib), a new multi-kinase inhibitor for the treatment of patients with advanced renal cell carcinoma

Proquad a new live vaccine for simultaneous vaccination against measles, mumps, rubella (German measles) and varicella (chickenpox) in children 12 months to 12 years of age (Proquad is also approved for use in children 12 months to 12 years of age if a second dose of measles, mumps, and rubella vaccine is to be administered)

Ranexa (ranolazine extended-release tablets), a new anti-anginal for the treatment of chronic angina

Rotateq (rotavirus vaccine, live, oral, pentavalent), a new vaccine for the prevention of rotavirus gastroenteritis in infants and children

Sutent (sunitinib malate), a new multi-kinase inhibitor for patients with advanced renal cell carcinoma, and gastrointestinal stromal tumor after disease progression on, or intolerance to, imatinib mesylate

Vivaglobin (immune globulin subcutaneous [human]), a new immune globulin for the treatment of patients with primary immunodeficiency.

You'll find the most complete data on more than 4,000 drugs by brand and generic name (both in the same convenient index), manufacturer, and product category.

Your 2007 PDR provides usage information and warnings, drug interactions, plus more than 2,000 full-size, full-color photos cross-referenced to the drug. You will also find: > Phonetic spelling for each listing > A key to controlled substances > Dosages > Clinical pharmacology > FDA use-in-pregnancy ratings > Adverse reactions > Contraindications > Pediatric use > And all other FDA-required information

]]> 2006 0 0 false Thu Apr 09 19:08:27 -0700 2009 Thu Apr 09 19:08:27 -0700 2009 49335376 934927 869587 1563635682 9781563635687 1 <![CDATA[2007 Physicians' Desk Reference]]> http://photo.goodreads.com/books/1179053764m/869587.jpg http://photo.goodreads.com/books/1179053764s/869587.jpg http://www.goodreads.com/book/show/869587.2007_Physicians_Desk_Reference 4.30 10 Physicians have turned to PDR for the latest word on prescription drugs for over 60 years! Today, PDR is considered the standard prescription drug reference and can be found in virtually every physician's office, hospital, and pharmacy in the United States. In fact, nine out of 10 doctors consider PDR their most important drug information reference source.

The 61st edition contains more than 3,000 pages—our most comprehensive edition ever! Our new format allows dramatically improved readability and easier access to the information you need now. Among the new drugs featured in this edition are:

Amitiza (lubiprostone), a new locally acting chloride-channel activator for the oral treatment of chronic idiopathic constipation in adults

Daytrana (methylphenidate transdermal system), a new once-daily transdermal patch formulation of methylphenidate for the treatment of attention deficit hyperactivity disorder

Nexavar (sorafenib), a new multi-kinase inhibitor for the treatment of patients with advanced renal cell carcinoma

Proquad a new live vaccine for simultaneous vaccination against measles, mumps, rubella (German measles) and varicella (chickenpox) in children 12 months to 12 years of age (Proquad is also approved for use in children 12 months to 12 years of age if a second dose of measles, mumps, and rubella vaccine is to be administered)

Ranexa (ranolazine extended-release tablets), a new anti-anginal for the treatment of chronic angina

Rotateq (rotavirus vaccine, live, oral, pentavalent), a new vaccine for the prevention of rotavirus gastroenteritis in infants and children

Sutent (sunitinib malate), a new multi-kinase inhibitor for patients with advanced renal cell carcinoma, and gastrointestinal stromal tumor after disease progression on, or intolerance to, imatinib mesylate

Vivaglobin (immune globulin subcutaneous [human]), a new immune globulin for the treatment of patients with primary immunodeficiency.

You'll find the most complete data on more than 4,000 drugs by brand and generic name (both in the same convenient index), manufacturer, and product category.

Your 2007 PDR provides usage information and warnings, drug interactions, plus more than 2,000 full-size, full-color photos cross-referenced to the drug. You will also find: > Phonetic spelling for each listing > A key to controlled substances > Dosages > Clinical pharmacology > FDA use-in-pregnancy ratings > Adverse reactions > Contraindications > Pediatric use > And all other FDA-required information

]]> 2006 4 0 false Sun Mar 15 08:50:09 -0700 2009 Sun Mar 15 08:50:09 -0700 2009 49019454 2120566 869587 1563635682 9781563635687 1 <![CDATA[2007 Physicians' Desk Reference]]> http://photo.goodreads.com/books/1179053764m/869587.jpg http://photo.goodreads.com/books/1179053764s/869587.jpg http://www.goodreads.com/book/show/869587.2007_Physicians_Desk_Reference 4.30 10 Physicians have turned to PDR for the latest word on prescription drugs for over 60 years! Today, PDR is considered the standard prescription drug reference and can be found in virtually every physician's office, hospital, and pharmacy in the United States. In fact, nine out of 10 doctors consider PDR their most important drug information reference source.

The 61st edition contains more than 3,000 pages—our most comprehensive edition ever! Our new format allows dramatically improved readability and easier access to the information you need now. Among the new drugs featured in this edition are:

Amitiza (lubiprostone), a new locally acting chloride-channel activator for the oral treatment of chronic idiopathic constipation in adults

Daytrana (methylphenidate transdermal system), a new once-daily transdermal patch formulation of methylphenidate for the treatment of attention deficit hyperactivity disorder

Nexavar (sorafenib), a new multi-kinase inhibitor for the treatment of patients with advanced renal cell carcinoma

Proquad a new live vaccine for simultaneous vaccination against measles, mumps, rubella (German measles) and varicella (chickenpox) in children 12 months to 12 years of age (Proquad is also approved for use in children 12 months to 12 years of age if a second dose of measles, mumps, and rubella vaccine is to be administered)

Ranexa (ranolazine extended-release tablets), a new anti-anginal for the treatment of chronic angina

Rotateq (rotavirus vaccine, live, oral, pentavalent), a new vaccine for the prevention of rotavirus gastroenteritis in infants and children

Sutent (sunitinib malate), a new multi-kinase inhibitor for patients with advanced renal cell carcinoma, and gastrointestinal stromal tumor after disease progression on, or intolerance to, imatinib mesylate

Vivaglobin (immune globulin subcutaneous [human]), a new immune globulin for the treatment of patients with primary immunodeficiency.

You'll find the most complete data on more than 4,000 drugs by brand and generic name (both in the same convenient index), manufacturer, and product category.

Your 2007 PDR provides usage information and warnings, drug interactions, plus more than 2,000 full-size, full-color photos cross-referenced to the drug. You will also find: > Phonetic spelling for each listing > A key to controlled substances > Dosages > Clinical pharmacology > FDA use-in-pregnancy ratings > Adverse reactions > Contraindications > Pediatric use > And all other FDA-required information

]]> 2006 0 0 false Thu Mar 12 06:52:58 -0700 2009 Thu Mar 12 06:53:01 -0700 2009 36398110 839188 869587 1563635682 9781563635687 1 <![CDATA[2007 Physicians' Desk Reference]]> http://photo.goodreads.com/books/1179053764m/869587.jpg http://photo.goodreads.com/books/1179053764s/869587.jpg http://www.goodreads.com/book/show/869587.2007_Physicians_Desk_Reference 4.30 10 Physicians have turned to PDR for the latest word on prescription drugs for over 60 years! Today, PDR is considered the standard prescription drug reference and can be found in virtually every physician's office, hospital, and pharmacy in the United States. In fact, nine out of 10 doctors consider PDR their most important drug information reference source.

The 61st edition contains more than 3,000 pages—our most comprehensive edition ever! Our new format allows dramatically improved readability and easier access to the information you need now. Among the new drugs featured in this edition are:

Amitiza (lubiprostone), a new locally acting chloride-channel activator for the oral treatment of chronic idiopathic constipation in adults

Daytrana (methylphenidate transdermal system), a new once-daily transdermal patch formulation of methylphenidate for the treatment of attention deficit hyperactivity disorder

Nexavar (sorafenib), a new multi-kinase inhibitor for the treatment of patients with advanced renal cell carcinoma

Proquad a new live vaccine for simultaneous vaccination against measles, mumps, rubella (German measles) and varicella (chickenpox) in children 12 months to 12 years of age (Proquad is also approved for use in children 12 months to 12 years of age if a second dose of measles, mumps, and rubella vaccine is to be administered)

Ranexa (ranolazine extended-release tablets), a new anti-anginal for the treatment of chronic angina

Rotateq (rotavirus vaccine, live, oral, pentavalent), a new vaccine for the prevention of rotavirus gastroenteritis in infants and children

Sutent (sunitinib malate), a new multi-kinase inhibitor for patients with advanced renal cell carcinoma, and gastrointestinal stromal tumor after disease progression on, or intolerance to, imatinib mesylate

Vivaglobin (immune globulin subcutaneous [human]), a new immune globulin for the treatment of patients with primary immunodeficiency.

You'll find the most complete data on more than 4,000 drugs by brand and generic name (both in the same convenient index), manufacturer, and product category.

Your 2007 PDR provides usage information and warnings, drug interactions, plus more than 2,000 full-size, full-color photos cross-referenced to the drug. You will also find: > Phonetic spelling for each listing > A key to controlled substances > Dosages > Clinical pharmacology > FDA use-in-pregnancy ratings > Adverse reactions > Contraindications > Pediatric use > And all other FDA-required information

]]> 2006 3 0 false Tue Oct 28 11:33:36 -0700 2008 Tue Oct 28 11:33:36 -0700 2008 32615245 1517848 869587 1563635682 9781563635687 1 <![CDATA[2007 Physicians' Desk Reference]]> http://photo.goodreads.com/books/1179053764m/869587.jpg http://photo.goodreads.com/books/1179053764s/869587.jpg http://www.goodreads.com/book/show/869587.2007_Physicians_Desk_Reference 4.30 10 Physicians have turned to PDR for the latest word on prescription drugs for over 60 years! Today, PDR is considered the standard prescription drug reference and can be found in virtually every physician's office, hospital, and pharmacy in the United States. In fact, nine out of 10 doctors consider PDR their most important drug information reference source.

The 61st edition contains more than 3,000 pages—our most comprehensive edition ever! Our new format allows dramatically improved readability and easier access to the information you need now. Among the new drugs featured in this edition are:

Amitiza (lubiprostone), a new locally acting chloride-channel activator for the oral treatment of chronic idiopathic constipation in adults

Daytrana (methylphenidate transdermal system), a new once-daily transdermal patch formulation of methylphenidate for the treatment of attention deficit hyperactivity disorder

Nexavar (sorafenib), a new multi-kinase inhibitor for the treatment of patients with advanced renal cell carcinoma

Proquad a new live vaccine for simultaneous vaccination against measles, mumps, rubella (German measles) and varicella (chickenpox) in children 12 months to 12 years of age (Proquad is also approved for use in children 12 months to 12 years of age if a second dose of measles, mumps, and rubella vaccine is to be administered)

Ranexa (ranolazine extended-release tablets), a new anti-anginal for the treatment of chronic angina

Rotateq (rotavirus vaccine, live, oral, pentavalent), a new vaccine for the prevention of rotavirus gastroenteritis in infants and children

Sutent (sunitinib malate), a new multi-kinase inhibitor for patients with advanced renal cell carcinoma, and gastrointestinal stromal tumor after disease progression on, or intolerance to, imatinib mesylate

Vivaglobin (immune globulin subcutaneous [human]), a new immune globulin for the treatment of patients with primary immunodeficiency.

You'll find the most complete data on more than 4,000 drugs by brand and generic name (both in the same convenient index), manufacturer, and product category.

Your 2007 PDR provides usage information and warnings, drug interactions, plus more than 2,000 full-size, full-color photos cross-referenced to the drug. You will also find: > Phonetic spelling for each listing > A key to controlled substances > Dosages > Clinical pharmacology > FDA use-in-pregnancy ratings > Adverse reactions > Contraindications > Pediatric use > And all other FDA-required information

]]> 2006 5 0 false Fri Sep 12 15:15:32 -0700 2008 Thu Sep 11 10:58:29 -0700 2008 Fri Sep 12 15:15:32 -0700 2008 31322761 1440162 869587 1563635682 9781563635687 1 <![CDATA[2007 Physicians' Desk Reference]]> http://photo.goodreads.com/books/1179053764m/869587.jpg http://photo.goodreads.com/books/1179053764s/869587.jpg http://www.goodreads.com/book/show/869587.2007_Physicians_Desk_Reference 4.30 10 Physicians have turned to PDR for the latest word on prescription drugs for over 60 years! Today, PDR is considered the standard prescription drug reference and can be found in virtually every physician's office, hospital, and pharmacy in the United States. In fact, nine out of 10 doctors consider PDR their most important drug information reference source.

The 61st edition contains more than 3,000 pages—our most comprehensive edition ever! Our new format allows dramatically improved readability and easier access to the information you need now. Among the new drugs featured in this edition are:

Amitiza (lubiprostone), a new locally acting chloride-channel activator for the oral treatment of chronic idiopathic constipation in adults

Daytrana (methylphenidate transdermal system), a new once-daily transdermal patch formulation of methylphenidate for the treatment of attention deficit hyperactivity disorder

Nexavar (sorafenib), a new multi-kinase inhibitor for the treatment of patients with advanced renal cell carcinoma

Proquad a new live vaccine for simultaneous vaccination against measles, mumps, rubella (German measles) and varicella (chickenpox) in children 12 months to 12 years of age (Proquad is also approved for use in children 12 months to 12 years of age if a second dose of measles, mumps, and rubella vaccine is to be administered)

Ranexa (ranolazine extended-release tablets), a new anti-anginal for the treatment of chronic angina

Rotateq (rotavirus vaccine, live, oral, pentavalent), a new vaccine for the prevention of rotavirus gastroenteritis in infants and children

Sutent (sunitinib malate), a new multi-kinase inhibitor for patients with advanced renal cell carcinoma, and gastrointestinal stromal tumor after disease progression on, or intolerance to, imatinib mesylate

Vivaglobin (immune globulin subcutaneous [human]), a new immune globulin for the treatment of patients with primary immunodeficiency.

You'll find the most complete data on more than 4,000 drugs by brand and generic name (both in the same convenient index), manufacturer, and product category.

Your 2007 PDR provides usage information and warnings, drug interactions, plus more than 2,000 full-size, full-color photos cross-referenced to the drug. You will also find: > Phonetic spelling for each listing > A key to controlled substances > Dosages > Clinical pharmacology > FDA use-in-pregnancy ratings > Adverse reactions > Contraindications > Pediatric use > And all other FDA-required information

]]> 2006 0 0 false Wed Aug 27 08:24:10 -0700 2008 Wed Aug 27 08:24:10 -0700 2008 15731105 904672 869587 1563635682 9781563635687 1 <![CDATA[2007 Physicians' Desk Reference]]> http://photo.goodreads.com/books/1179053764m/869587.jpg http://photo.goodreads.com/books/1179053764s/869587.jpg http://www.goodreads.com/book/show/869587.2007_Physicians_Desk_Reference 4.30 10 Physicians have turned to PDR for the latest word on prescription drugs for over 60 years! Today, PDR is considered the standard prescription drug reference and can be found in virtually every physician's office, hospital, and pharmacy in the United States. In fact, nine out of 10 doctors consider PDR their most important drug information reference source.

The 61st edition contains more than 3,000 pages—our most comprehensive edition ever! Our new format allows dramatically improved readability and easier access to the information you need now. Among the new drugs featured in this edition are:

Amitiza (lubiprostone), a new locally acting chloride-channel activator for the oral treatment of chronic idiopathic constipation in adults

Daytrana (methylphenidate transdermal system), a new once-daily transdermal patch formulation of methylphenidate for the treatment of attention deficit hyperactivity disorder

Nexavar (sorafenib), a new multi-kinase inhibitor for the treatment of patients with advanced renal cell carcinoma

Proquad a new live vaccine for simultaneous vaccination against measles, mumps, rubella (German measles) and varicella (chickenpox) in children 12 months to 12 years of age (Proquad is also approved for use in children 12 months to 12 years of age if a second dose of measles, mumps, and rubella vaccine is to be administered)

Ranexa (ranolazine extended-release tablets), a new anti-anginal for the treatment of chronic angina

Rotateq (rotavirus vaccine, live, oral, pentavalent), a new vaccine for the prevention of rotavirus gastroenteritis in infants and children

Sutent (sunitinib malate), a new multi-kinase inhibitor for patients with advanced renal cell carcinoma, and gastrointestinal stromal tumor after disease progression on, or intolerance to, imatinib mesylate

Vivaglobin (immune globulin subcutaneous [human]), a new immune globulin for the treatment of patients with primary immunodeficiency.

You'll find the most complete data on more than 4,000 drugs by brand and generic name (both in the same convenient index), manufacturer, and product category.

Your 2007 PDR provides usage information and warnings, drug interactions, plus more than 2,000 full-size, full-color photos cross-referenced to the drug. You will also find: > Phonetic spelling for each listing > A key to controlled substances > Dosages > Clinical pharmacology > FDA use-in-pregnancy ratings > Adverse reactions > Contraindications > Pediatric use > And all other FDA-required information

]]> 2006 4 0 false Mon Feb 18 15:55:41 -0800 2008 Mon Feb 18 15:55:47 -0800 2008 8304363 578047 869587 1563635682 9781563635687 1 <![CDATA[2007 Physicians' Desk Reference]]> http://photo.goodreads.com/books/1179053764m/869587.jpg http://photo.goodreads.com/books/1179053764s/869587.jpg http://www.goodreads.com/book/show/869587.2007_Physicians_Desk_Reference 4.30 10 Physicians have turned to PDR for the latest word on prescription drugs for over 60 years! Today, PDR is considered the standard prescription drug reference and can be found in virtually every physician's office, hospital, and pharmacy in the United States. In fact, nine out of 10 doctors consider PDR their most important drug information reference source.

The 61st edition contains more than 3,000 pages—our most comprehensive edition ever! Our new format allows dramatically improved readability and easier access to the information you need now. Among the new drugs featured in this edition are:

Amitiza (lubiprostone), a new locally acting chloride-channel activator for the oral treatment of chronic idiopathic constipation in adults

Daytrana (methylphenidate transdermal system), a new once-daily transdermal patch formulation of methylphenidate for the treatment of attention deficit hyperactivity disorder

Nexavar (sorafenib), a new multi-kinase inhibitor for the treatment of patients with advanced renal cell carcinoma

Proquad a new live vaccine for simultaneous vaccination against measles, mumps, rubella (German measles) and varicella (chickenpox) in children 12 months to 12 years of age (Proquad is also approved for use in children 12 months to 12 years of age if a second dose of measles, mumps, and rubella vaccine is to be administered)

Ranexa (ranolazine extended-release tablets), a new anti-anginal for the treatment of chronic angina

Rotateq (rotavirus vaccine, live, oral, pentavalent), a new vaccine for the prevention of rotavirus gastroenteritis in infants and children

Sutent (sunitinib malate), a new multi-kinase inhibitor for patients with advanced renal cell carcinoma, and gastrointestinal stromal tumor after disease progression on, or intolerance to, imatinib mesylate

Vivaglobin (immune globulin subcutaneous [human]), a new immune globulin for the treatment of patients with primary immunodeficiency.

You'll find the most complete data on more than 4,000 drugs by brand and generic name (both in the same convenient index), manufacturer, and product category.

Your 2007 PDR provides usage information and warnings, drug interactions, plus more than 2,000 full-size, full-color photos cross-referenced to the drug. You will also find: > Phonetic spelling for each listing > A key to controlled substances > Dosages > Clinical pharmacology > FDA use-in-pregnancy ratings > Adverse reactions > Contraindications > Pediatric use > And all other FDA-required information

]]> 2006 4 0 false Fri Oct 26 22:48:31 -0700 2007 Fri Oct 26 22:48:34 -0700 2007 4385101 246059 869587 1563635682 9781563635687 1 <![CDATA[2007 Physicians' Desk Reference]]> http://photo.goodreads.com/books/1179053764m/869587.jpg http://photo.goodreads.com/books/1179053764s/869587.jpg http://www.goodreads.com/book/show/869587.2007_Physicians_Desk_Reference 4.30 10 Physicians have turned to PDR for the latest word on prescription drugs for over 60 years! Today, PDR is considered the standard prescription drug reference and can be found in virtually every physician's office, hospital, and pharmacy in the United States. In fact, nine out of 10 doctors consider PDR their most important drug information reference source.

The 61st edition contains more than 3,000 pages—our most comprehensive edition ever! Our new format allows dramatically improved readability and easier access to the information you need now. Among the new drugs featured in this edition are:

Amitiza (lubiprostone), a new locally acting chloride-channel activator for the oral treatment of chronic idiopathic constipation in adults

Daytrana (methylphenidate transdermal system), a new once-daily transdermal patch formulation of methylphenidate for the treatment of attention deficit hyperactivity disorder

Nexavar (sorafenib), a new multi-kinase inhibitor for the treatment of patients with advanced renal cell carcinoma

Proquad a new live vaccine for simultaneous vaccination against measles, mumps, rubella (German measles) and varicella (chickenpox) in children 12 months to 12 years of age (Proquad is also approved for use in children 12 months to 12 years of age if a second dose of measles, mumps, and rubella vaccine is to be administered)

Ranexa (ranolazine extended-release tablets), a new anti-anginal for the treatment of chronic angina

Rotateq (rotavirus vaccine, live, oral, pentavalent), a new vaccine for the prevention of rotavirus gastroenteritis in infants and children

Sutent (sunitinib malate), a new multi-kinase inhibitor for patients with advanced renal cell carcinoma, and gastrointestinal stromal tumor after disease progression on, or intolerance to, imatinib mesylate

Vivaglobin (immune globulin subcutaneous [human]), a new immune globulin for the treatment of patients with primary immunodeficiency.

You'll find the most complete data on more than 4,000 drugs by brand and generic name (both in the same convenient index), manufacturer, and product category.

Your 2007 PDR provides usage information and warnings, drug interactions, plus more than 2,000 full-size, full-color photos cross-referenced to the drug. You will also find: > Phonetic spelling for each listing > A key to controlled substances > Dosages > Clinical pharmacology > FDA use-in-pregnancy ratings > Adverse reactions > Contraindications > Pediatric use > And all other FDA-required information

]]> 2006 4 0 false Fri Aug 10 21:12:41 -0700 2007 Fri Aug 10 21:12:41 -0700 2007 2336946 67717 869587 1563635682 9781563635687 1 <![CDATA[2007 Physicians' Desk Reference]]> http://photo.goodreads.com/books/1179053764m/869587.jpg http://photo.goodreads.com/books/1179053764s/869587.jpg http://www.goodreads.com/book/show/869587.2007_Physicians_Desk_Reference 4.30 10 Physicians have turned to PDR for the latest word on prescription drugs for over 60 years! Today, PDR is considered the standard prescription drug reference and can be found in virtually every physician's office, hospital, and pharmacy in the United States. In fact, nine out of 10 doctors consider PDR their most important drug information reference source.

The 61st edition contains more than 3,000 pages—our most comprehensive edition ever! Our new format allows dramatically improved readability and easier access to the information you need now. Among the new drugs featured in this edition are:

Amitiza (lubiprostone), a new locally acting chloride-channel activator for the oral treatment of chronic idiopathic constipation in adults

Daytrana (methylphenidate transdermal system), a new once-daily transdermal patch formulation of methylphenidate for the treatment of attention deficit hyperactivity disorder

Nexavar (sorafenib), a new multi-kinase inhibitor for the treatment of patients with advanced renal cell carcinoma

Proquad a new live vaccine for simultaneous vaccination against measles, mumps, rubella (German measles) and varicella (chickenpox) in children 12 months to 12 years of age (Proquad is also approved for use in children 12 months to 12 years of age if a second dose of measles, mumps, and rubella vaccine is to be administered)

Ranexa (ranolazine extended-release tablets), a new anti-anginal for the treatment of chronic angina

Rotateq (rotavirus vaccine, live, oral, pentavalent), a new vaccine for the prevention of rotavirus gastroenteritis in infants and children

Sutent (sunitinib malate), a new multi-kinase inhibitor for patients with advanced renal cell carcinoma, and gastrointestinal stromal tumor after disease progression on, or intolerance to, imatinib mesylate

Vivaglobin (immune globulin subcutaneous [human]), a new immune globulin for the treatment of patients with primary immunodeficiency.

You'll find the most complete data on more than 4,000 drugs by brand and generic name (both in the same convenient index), manufacturer, and product category.

Your 2007 PDR provides usage information and warnings, drug interactions, plus more than 2,000 full-size, full-color photos cross-referenced to the drug. You will also find: > Phonetic spelling for each listing > A key to controlled substances > Dosages > Clinical pharmacology > FDA use-in-pregnancy ratings > Adverse reactions > Contraindications > Pediatric use > And all other FDA-required information

]]> 2006 5 0 false Sun Jun 24 16:53:19 -0700 2007 Sun Jun 24 16:53:26 -0700 2007 8 http://www.goodreads.com/book_link/follow/8?book_id=869587